bpa controversy

42
BPA CONTROVERSY

Upload: alvisyamashita

Post on 06-Sep-2014

173 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Bpa Controversy

BPA CONTROVERSY

Page 2: Bpa Controversy

BPA (Bisphenol A)

-is an important industrial chemical compound used to

make polycarbonate plastic and certain type of epoxy resins.

Page 3: Bpa Controversy

- used in many products such as refillable beverage containers,

compact disks, some plastic eating utensils, and impact-resistant safety and sports equipment.

Page 4: Bpa Controversy

これ は  BPA  です。

Page 5: Bpa Controversy
Page 6: Bpa Controversy

HISTORY ( 歴 史 )

1905 – synthesize by Thomas Zincke of University of Marburg, Germany.

1953 – Dr. Hermann Schnell of Bayer and Dr. Dan Fox of GE independently develop manufacturing procedure on developing Polycarbonate using BPA as starting material.

Page 7: Bpa Controversy

…. 1958 – commercial production of such plastic

started in the USA.

1959 – commercial production started in Europe

1963 – declared as a GRAS by the FDA

Has been extensively studied for the past 50 years.

Page 8: Bpa Controversy

How do we get exposed…?

Diet Almost 93% of the 2517 Americans tested are

exposed to it. Children have the highest level followed by

teens and then adult.

Page 9: Bpa Controversy

Environmental About 6 billion pounds of BPA products are

produced each year, 2 hundred thousand pounds of the chemical is released into the atmosphere

Page 10: Bpa Controversy

Dietary Intake for BPA

0.05mg/kg BW.D

Page 11: Bpa Controversy

…Safe or Dangerous or

Safe?

Page 12: Bpa Controversy
Page 13: Bpa Controversy

WHY is it controversial?!

Health Concerns Carcinogenicity

Alleged to cause prostate, breast and uterus cancer

Reproductive and Developmental Toxicity Autism, ADHD, early puberty, heart ailments and

obesity, neurobehavioral problems Low-Dose Hypothesis

Page 14: Bpa Controversy

The experimental design used to proved its safety.

Page 15: Bpa Controversy

THE PRO SIDE : BPA is SAFE!

1) BPA is not carcinogenic and does not selectively affect reproduction

or development. The No-Observed-Adverse- Effect-Level (NOAEL) for

BPA,confirmed in multiple laboratory animal tests, is 50 mg/kg

body weight/day;

Page 16: Bpa Controversy

2) The estimated dietary intake of BPA from polycarbonate plastic

and epoxy resin food contact applications, based on the results of multiple migration studies with

consistent results, is less than 0.000118 mg/kg body weight/day;

and

Page 17: Bpa Controversy

3) This potential human exposure to BPA is more than 400 times lower than the maximum acceptable or “reference”

dose for BPA of 0.05 mg/kg body weight/day established by the U.S. Environmental Protection Agency, which is derived from the NOAEL.

Page 18: Bpa Controversy

1st Round!

PRO Cagen, et al. (1999) and Ashby, et. al (1999)

- Both study resulted in a No-Observed-adverse-effect level which disclaimed the Low-Dose Hypothesis

Page 19: Bpa Controversy

Low Dose Hypothesis

a hypothesis that has been advanced claiming that exposure to

extremely low doses of certain substances could cause adverse

health effects in humans.

(series of experiments in 1997 and 1998)

Page 20: Bpa Controversy

But according to U.S. NTP….

“There is credible evidence that low doses of BPA can cause effects on specific endpoints. However, due to the inability of other credible studies in several different laboratories to observe low dose effects of BPA, and the consistency of these negative studies, the Subpanel is not

Page 21: Bpa Controversy

persuaded that a low dose effect of BPA has been conclusively established as a general or reproducible finding. In addition, for those studies in which low dose effects have been observed, the mechanism(s) is uncertain (i.e., hormone related or otherwise) and the biological relevance is unclear.” (emphasis added)

Page 22: Bpa Controversy

…. In 1995, the Bisphenol A Toxicology Task Force of

the Society of the Plastics Industry, Inc. completed a comprehensive review of available data on BPA (BATTF, 1995) which is consistent with BPA (EU

RAR, 2002) stating that there is no evidence to say that low dosage of BPA can cause reproductive

and developmental problems.

Page 23: Bpa Controversy

Study by US NTP, 1982 and EU RAR, 2002 which studied cancer bioassays of rats that

were exposed with BPA for a lifetime suggested that there was no convincing

effects to say BPA’s carcinogenicity.

Page 24: Bpa Controversy

According to studies by different government agencies in Europe, USA, Japan and private sectors there is minimal leaching that occurs

in BPA products and it cannot exceed the dietary intake levels.

Page 25: Bpa Controversy

1. U.S. Food and Drug Administration (FDA) on baby bottles, water bottles and cut portions of baby bottles under “typical/normal use” conditions (Biles et al, 1997);

Page 26: Bpa Controversy

2. U.K. Ministry of Agriculture, Fisheries and Food (MAFF) on baby bottles subjected to 20-50 cycles of cleaning, sterilizing and simulated use (Mountfort et al, 1997; MAFF, 1997);

3. U.K. Department of Trade and Industry (DTI), Consumer Affairs Directorate on baby bottles handled under “realistic worst-case conditions of use” (Earls et al, 2000);

Page 27: Bpa Controversy

4. Japanese National Institute of Health Sciences (NIHS) on tableware and baby bottles under conditions representative of normal consumer use (Kawamura et al, 1998); and

5. Society of the Plastics Industry, Inc. (SPI) on polycarbonate discs under the most rigorous conditions recommended by FDA (Howe and Borodinsky, 1998).

Page 28: Bpa Controversy

However . . .

Page 29: Bpa Controversy

THE CON SIDEBPA effects in mice

and ratsHuman health trends

Prostate hyperplasia and cancer

Mammary hyperplasia and cancer

CancerProstate cancer

increaseBreast cancer increase

Abnormal urethra/obstruction

Sperm count decreaseEarly puberty in females

Ovarian cysts/uterine fibroids

Abnormal oocyte chromosomes

Male and female

reproductive system

HypospadiasSperm count decrease

Early sexual maturation

PCOS/uterine fibroidsMiscarriage

Page 30: Bpa Controversy

Body weight increaseInsulin resistance

Metabolic disease

Obesity increaseType 2 diabetes

Hyperactivity/impaired learning

Abnormal play behavior

Abnormal socio-sexual behavior

Brain and behavior

ADHDAutism

Page 31: Bpa Controversy

The question with the experiments: these publications did not acknowledge

source of funding (Cagen, et al. and Ashby, et al. 1999)

both of these industry-funded studies also failed to find any effects of the positive control estrogenic drug diethylstilbestrol (DES) as reported by Vom Saal, et al. (1998)

Page 32: Bpa Controversy

…. Failure of FDA to identify the faulty studies.

Dr. George Pauli’s statement in 1999, 2005 The use of CD-SD mice as subjects in studies

that resulted into a NOAEL. Use of questionable studies to say that BPA

is safe. (Tyl, et al. 2008 study) Inconsistency of the scientists Unreported contamination of specimens

Page 33: Bpa Controversy

In a review as of 2005, out of 115 studies investigating “low doses” of BPA in experiments conducted with laboratory animals, over 90% of government-funded studies conducted by academic and government scientists with no financial conflicts concerning BPA reported finding harm, while 100% of industry-funded studies reported no harm.

Page 34: Bpa Controversy

NTP STUDY 2008 vs. FDA 2008 draft risk assessment of BPA

Page 35: Bpa Controversy

FDA

Used in its draft which still insist that BPA safety are experiments conducted by Tyl, et. al (2002) and Tyl, et. Al (2008), which used GLP. 2002, use of CD-SD mouse 2008, inconsistent report of the scientists

about the age of the mouse used in the experiment.

Page 36: Bpa Controversy

Released on August 18, 2008 days after NTP released its own draft that involved a 2 year review of published studies concerning BPA by the Center for the Evaluation of Risk to Human Reproduction (CERHR)

Page 37: Bpa Controversy

NTP 2008

The NTP concluded that there was some concern for adverse effects of BPA on some

aspects of the reproductive system (in particularly the prostate) and development (in

particular neuro-behavioral development), with the primary threat occurring during early

life (NTP, 2008).

Page 38: Bpa Controversy

The fear Factor~!

North American Metal Packaging Alliance, Inc.

May 28, 2009, 10:00 a.m. - 3:10 p.m. EDTRE: BPA Joint Trade Association Meeting on Communications StrategyMeeting Goal: Develop potential communication/media strategies around BPA

Page 39: Bpa Controversy

PRO SIDE CON SIDESociety of Plastics Industry, Inc.Bisphenol A Group Sector of European Chemical Industry CouncilU.S. FDAJapan NIHSAmerican Chemist Council

University scientists like Dr. vom SaalCanadian GovernmentAlaska Community on ToxicsEnvironmental Working Group

Page 40: Bpa Controversy

References BATTF (Bisphenol A Toxicology Task Force), 1995, “Bisphenol A: Summary of the Key Toxicology Studies, Estrogenicity Data and an Evaluation of the No-Observed-Effect-Level (NOEL),” The Society

of the Plastics Industry, Inc., Washington, D.C., February 9, 1995. Biles, J. E., T. P. McNeal, T. H. Begley and H. C. Hollifield, 1997, “Determination of Bisphenol-A in Reusable Polycarbonate Food-Contact Plastics and Migration to Food-Simulating Liquids,” Journal of Agricultural and Food Chemistry, vol. 43, pages 3541-3544. BPA INFO (Bisphenol A Information Sheet), 2002a, “Low-Dose Hypothesis Unproven for Bisphenol A.” Available on the Internet at http://www.bisphenol-a.org/infosheets/Low_Dose.pdf. BPA INFO (Bisphenol A Information Sheet), 2002b, “Safety of Polycarbonate Plastic.” Available on the Internet at http://www.bisphenol-a.org/infosheets/Polycarbonate.pdf. BPA INFO (Bisphenol A Information Sheet), 2002c, “Safety of Epoxy Can Coatings.” Available on the Internet at http://www.bisphenol-a.org/infosheets/Epoxy.pdf. CSTEE (Scientific Committee on Toxicity, Ecotoxicity and the Environment), 2002, “Opinion on the results of the Risk Assessment of Bisphenol A Human Health Part.” Available on the Internet at http://europa.eu.int/comm/food/fs/sc/sct/out156_en.pdf. Earls, A. O., C. A. Clay, and J. H. Braybrook, 2000, “Preliminary Investigation into the Migration of Bisphenol A from Commercially-Available Polycarbonate Baby Feeding Bottles,” Final Report prepared

by LGC Consumer Safety Team for the Consumer Affairs Directorate, Department of Trade and Industry, May 2000. Ema, M., S. Fujii, M. Furukawa, M. Kiguchi, T. Ikka, and A. Harazono, 2001, Reproductive Toxicology, vol. 15, pages 505-523. EC SCF (European Commission Scientific Committee on Food), 2002, “Synoptic Document,” European Commission, Health & Consumer Protection Directorate – General, January 2002. Available on-

line at http://cpf.jrc.it/webpack/. EPA (U.S. Environmental Protection Agency), Bisphenol A, CASRN 80-05-7, IRIS, Integrated Risk Information System, on-line, 1993. Available on the Internet at http://www.epa.gov/iris/. EU RAR (European Union), 2002, “Risk Assessment of Bisphenol-A.” Available on the Internet at http://ecb.jrc.it/existing-chemicals. FDA (U.S. Food and Drug Administration), 2002, “Preparation of Food Contact Notifications and Food Additive Petitions for Food Contact Substances: Chemistry Recommendations,” Center for Food Safety and Applied Nutrition, Office of Food Additive Safety, FDA, Washington, D.C., April 2002. Goodson, A., W. Summerfield, and I. Cooper, 2002, “Survey of bisphenol A and bisphenol F in canned foods,” Food Additives and Contaminants, vol. 19, pages 796-802. Haighton, L. A., J. J. Hlywka, J. Doull, R. Kroes, B. S. Lynch, and I. C. Munro, 2002, “An Evaluation of the PossibleCarcinogenicity of Bisphenol A to Humans,” Regulatory Toxicology and Pharmacology,

vol. 35, pages 238-254. Howe, S.R. and L. Borodinsky, 1998, “Potential Exposure to Bisphenol A from Food-Contact Use of Polycarbonate Resins,” Food Additives and Contaminants, vol. 15, pages 370-375. Howe, S.R., L. Borodinsky and R.S. Lyon, 1998, “Potential Exposure to Bisphenol A From Food-Contact Uses of Epoxy Can Coatings,” Journal of Coatings Technology, vol. 70, no. 877, pages 69-74. Kawamura, Y., Y. Koyama, Y. Takeda and T. Yamada, 1998, “Migration of Bisphenol A from Polycarbonate Products,” Journal of Food Hygiene, vol. 99, pages 206-212, translated by Schreiber

Translation, Rockville, MD. MAFF (U.K. Ministry of Agriculture, Fisheries and Food), 1997, “Investigations into the Potential Degradation of Polycarbonate Baby Bottles During Sterilization with Consequent Release of Bisphenol A,”

Central Science. Laboratory Report FD 97/08, MAFF R&D and Surveillance Report 253, Ministry of Agriculture, Fisheries and Food Library, Noble House, London METI (Japanese Ministry of Economy, Trade and Industry), 2002, “Hazard Assessment of Some Chemical Substances Which Have Been Suspected to be Endocrine Disrupters,” pages 328-361. Mountfort, K.A., J. Kelly, S.M. Jickells and L. Castle, 1997, Food Additives and Contaminants, vol. 14, pages 737-740. NRC (U.S. National Research Council), 1983, “Risk Assessment in the Federal Government: Managing the Process,” National Academy Press, Washington, D.C. NTP (U.S. National Toxicology Program), 1982, “Carcinogenesis Bioassay of Bisphenol A (CAS No. 80-05-7) in F344 Rats and B6C3F1 Mice (Feed Study), Technical Report Series No. 215,” NTP,

Research Triangle Park, N.C. NTP (U.S. National Toxicology Program), 2001, “Report of t he Endocrine Disruptors Low-Dose Peer Review,” NTP, Research Triangle Park, N.C, available on-line at:

http://ntpserver.niehs.nih.gov/htdocs/liason/LowDoseWebPage.html. SCF, 2002, “Opinion of the Scientific Committee on Food on Bisphenol A”, April 17. Available on the Internet at http://europa.eu.int/comm/food/fs/sc/scf/index_en.html. Tyl, R. W., C. B. Myers, M. C. Marr, B. F. Thomas, A. R. Keimowitz, D. R. Brine, M. M. Veselica, P. A. Fail, T. Y. Chang, J. C. Seely, R. L. Joiner, J. H. Butala, S. S. Dimond, S. Z. Cagen, R. N. Shiotsuka, G. D. Stropp, and J. M. Waechter, 2002, “Three-Generation Reproductive Toxicity Study of Dietary Bisphenol A

in CD Sprague-Dawley Rats,” Toxicological Sciences, vol. 68, pages 121-146. UK FSA (United Kingdom Food Standards Agency), 2001, “Survey of Bisphenols in Canned Foods”, March 2001. Available on the Internet at http://www.food.gov.uk/science/surveillance/fsis-2001/bisphenols.

Page 41: Bpa Controversy

Ashby J, Tinwell H, Haseman J. (1999) Lack of effects for low dose levels of bisphenol A (BPA) and diethylstilbestrol (DES) on the prostate gland of CF1 mice exposed in utero. Reg Tox Pharm 30, 156-166. Ashby J, Tinwell H, Lefevre PA, Joiner R, Haseman J. (2003) The effect on sperm production in adult Sprague-Dawley rats exposed by gavage to bisphenol A between postnatal days 91-97. Toxicol. Sci. 74,

129-138. Cagen SZ, Waechter JM, Dimond SS, Breslin WJ, Butala JH, Jekat FW, Joiner RL, Shiotsuka RN, Veenstra GE, Harris LR. (1999) Normal reproductive organ development in CF-1 mice following prenatal

exposure to Bisphenol A. Tox Sci 11, 15-29. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116, 39-44. Canada E. 2008. Draft Screening Assessment for The Challenge Phenol, 4,4' -(1-methylethylidene)bis- (Bisphenol A). Chemical Abstracts Service Registry Number 80-05-7. http://www.ec.gc.ca/substances/ese/eng/challenge/batch2/batch2_80-05-7.cfm. . Colerangle JB, Roy D. (1997) Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats. J Steroid Biochem Mol Biol 60, 153-160. Gupta C. (2000) The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation. Urol Res 28, 223-229. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D. (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA

300, 1303-1310. Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, et. al. (2009) Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of

bisphenol A. Environ Health Perspect 117, 309-315. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the

xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105, 70-76. Newbold R. (1995) Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103, 83-87. Newbold RR, Jefferson WN, Padilla-Banks E. (2007) Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24, 253-258. Newbold RR, Jefferson WN, Padilla-Banks E, Haseman J. (2004) Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects.

Reprod Toxicol 18, 399-406. NTP. 2008. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. September 2008. http://cerhr.niehs.nih.gov/chemicals/bisphenol/bisphenoleval. html.

Accessed September 3, 2008. (Program NT, ed): NIH Publication No. 08 – 5994. Richter CA, Taylor JA, Ruhlen RR, Welshons WV, vom Saal FS. (2007b) Estradiol and bisphenol A stimulate androgen receptor and estrogen receptor gene expression in fetal mouse prostate cells. Environ

Health Perspect 115, 902-908. Ruhlen RL, Howdeshell KL, Mao J, Taylor JA, Bronson FH, Newbold RR, Welshons WV, vom Saal FS. (2008) Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal

estrogenization syndrome" and obesity in CD-1 mice. Environ Health Perspect 116, 322-328. Sakaue M, Ohsako S, Ishimura R, Kurosawa S, Kurohmaru M, Hayashi Y, Aoki Y, Yonemoto J, Tohyama C. (2001) Bisphenol A affects spermatogenesis in the adult rat even at a low dose. J Occupational

Health 43, 185-190. Stahlhut RW, Welshons WV, Swan SH. (2009) Bisphenol A data in NHANES suggest longer than expected half-life, substantial non-food exposure, or both. Environ Health Perspect, doi: 10.1289/ehp.0800376

(available at http://dx.doi.org/) Online 0800328 January 0802009. Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. (1997) The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinol 138, 1780-1786. Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, Ben-Jonathan N. (1998) The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract.

Endocrinol 139, 2741-2747. Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS. (2005) Estrogenic chemicals in plastic and oral contraceptives disrupt development of the mouse prostate and urethra. Proc Natl

Acad Sci 102, 7014-7019. Toloken S. (1998) SPI study disputes endocrine disruptor findings. Plastic News October 16. Tyl R, Myers C, Marr M, Sloan CS, Castillo N, Veselica MM, Seely JC, Dimond SS, Van Miller JP, Shiotsuka RS, et al. (2008b) Two-Generation Reproductive Toxicity Evaluation of Dietary 17ß- Estradiol (E2;

CAS No. 50-28-2) in CD-1® (Swiss) Mice. Toxicol Sci 102, 392-412. Tyl RW, Myers C, Marr M, Sloan CS, Castillo N, Veselica MM, Seely JC, Dimond SS, Van Miller JP, Shiotsuka RS, et al. (2008a) Two-Generation Reproductive Toxicity Study of Dietary Bisphenol A (BPA) in

CD-1® (Swiss) Mice. Toxicol Sci 102, 362-284. Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, Veselica MM, Fail PA, Chang TY, Seely JC, et al. (2002) Three-generation reproductive toxicity study of dietary bisphenol A in CD

Sprague-Dawley rats. Toxicol Sci 68, 121-146. vom Saal FS. 2008. Bisphenol A: Update of current published studies. Available: http://endocrinedisruptors.missouri.edu/vomsaal/vomsaal.html [accessed Febriary 22, 2008]. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Jr., Hauser R, Heindel JJ, et al. (2007) Chapel Hill bisphenol A expert panel consensus statement:

integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24, 131-138. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, Parmigiani S, Welshons WV. (1998) A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on

the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 14, 239-260. vom Saal FS, Hughes C. (2005) An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113, 926-933. vom Saal FS, Myers JP. (2008) Bisphenol A and risk of metabolic disorders. JAMA 300, 1353-1355. vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, Dhar MD, Ganjam VK, Parmigiani S, Welshons WV. (1997) Prostate enlargement in mice due to fetal exposure to low doses of

estradiol or diethylstilbestrol and opposite effects at high doses. Proc Nat Acad Sci 94, 2056-2061. vom Saal FS, Welshons WV. (2006) Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100, 50-76.

Page 42: Bpa Controversy

毎度あり!!